Thermo Fisher Scientific (TMO) Income from Continuing Operations (2009 - 2026)
Thermo Fisher Scientific (TMO) posted Income from Continuing Operations of 1664000000.0 for Q1 2026, down 16.8% quarter-over-quarter from 2000000000.0 in Q4 2025, and up 9.11% year-on-year from 1525000000.0 in Q1 2025.
Thermo Fisher Scientific (TMO) Income from Continuing Operations (2009 - 2026) Analysis & Trends
Thermo Fisher Scientific (TMO) has reported Income from Continuing Operations for 18 consecutive years, with 1664000000.0 the latest figure, recorded in Q1 2026.
- Income from Continuing Operations for Q1 2026 came in at 1664000000.0, up 9.11% year-over-year; the trailing twelve-month figure through Mar 2026 was 6900000000.0 (up 4.61% YoY), and the FY2025 annual result was 6761000000.0, up 5.97% from the prior year.
- Income from Continuing Operations was 1664000000.0 for Q1 2026 at Thermo Fisher Scientific, down from 2000000000.0 in the prior quarter.
- Over five years, Income from Continuing Operations peaked at 2239000000.0 in Q2 2022 and troughed at 1308000000.0 in Q1 2024.
- Average Income from Continuing Operations over 5 years is 1644117647.06, with a median of 1619000000.0 recorded in 2025.
- Year-over-year, Income from Continuing Operations tumbled 41.18% in 2023 and rose 18.8% in 2024.
- Over 5 years, Income from Continuing Operations stood at 1604000000.0 in 2022, then grew by 0.19% to 1607000000.0 in 2023, then grew by 11.45% to 1791000000.0 in 2024, then rose by 11.67% to 2000000000.0 in 2025, then dropped by 16.8% to 1664000000.0 in 2026.
- Per Business Quant data, the three most recent Income from Continuing Operations figures were 1664000000.0 in Q1 2026, 2000000000.0 in Q4 2025, and 1619000000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn | -72.00 Mn |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn | 1.66 Bn |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn | 1.03 Bn |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn | 278.45 Mn |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn | -85.11 Mn |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn | 339.00 Mn |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn | 269.00 Mn |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn | 134.00 Mn |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn | 169.45 Mn |
| 10 | Quest Diagnostics | 23.76 Bn | 23.67 Bn | 942.00 Mn | 260.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 28, 2026 | 1.66 Bn |
| Dec 31, 2025 | 2.00 Bn |
| Sep 27, 2025 | 1.62 Bn |
| Jun 28, 2025 | 1.62 Bn |
| Mar 29, 2025 | 1.53 Bn |
| Dec 31, 2024 | 1.79 Bn |
| Sep 28, 2024 | 1.64 Bn |
| Jun 29, 2024 | 1.64 Bn |
| Mar 30, 2024 | 1.31 Bn |
| Dec 31, 2023 | 1.61 Bn |
| Sep 30, 2023 | 1.71 Bn |
| Jul 1, 2023 | 1.38 Bn |
| Apr 1, 2023 | 1.32 Bn |
| Dec 31, 2022 | 1.60 Bn |
| Oct 1, 2022 | 1.57 Bn |
| Jul 2, 2022 | 1.72 Bn |
| Apr 2, 2022 | 2.24 Bn |
| Dec 31, 2021 | 1.66 Bn |
| Oct 2, 2021 | 1.91 Bn |
| Jul 3, 2021 | 1.83 Bn |